Report
EUR 900.30 For Business Accounts Only

Cigarettes in Malaysia, 2017

Synopsis

The market for cigarettes in Malaysia has experienced contrasting trends in recent years. Recently the legitimate market has suffered badly from a series of price and tax increases, culminating in a combination of tax rises and a crackdown on black market activities. Malaysia is a production centre of choice for BAT, PMI and JTI to service other South East Asian regional markets, although output fell by around a third in 2013 to 17.87 billion pieces and was 16.33 billion pieces in 2015. Imports have not historically been very significant, although officially reported volumes appear unreliable.

Summary

The market is dominated by three major international manufacturers: BAT, JTI and PMI. British American Tobacco (BAT) Malaysia is the clear leader with a 61.2% share in 2014,leading the premium market while JTI is the leader in the value-for-money market Forecasts for 2015 remain pessimistic with a further 7.2% fall in sales expected to 9.8 billion pieces. There are no signs that the industry expects a substantial reduction in black market levels in the short term as price is such an important factor for the vast majority of consumers.

Scope

Cigarette consumption in Malaysia has fluctuated since 1990 although more recently been in sharp decline. A 9.7% fall in 2009, a 1.9% drop in 2010 and a 2.3% fall in 2011 were a result of rises in excise duty and increased non-duty paid sales. Although volumes were up by 2.7% in 2012, this was in anticipation of another tax hike at the beginning of 2013. The impact of this rise was to reduce sales by 16.2% to 12.18 billion pieces with another tax inspired fall of 13.3% to 10.56 billion pieces in 2014. Sales are set to decline again in 2015.

Reasons To Buy

Get a detailed understanding of consumption to align your sales and marketing efforts with the latest trends in the market. Identify the areas of growth and opportunities, which will aid effective marketing planning. The differing growth rates in regional product sales drive fundamental shifts in the market. This report provides detailed, authoritative data on these changes - prime intelligence for marketers. Understand the market dynamics and essential data to benchmark your position and to identify where to compete in the future.
Provider
GlobalData Plc
GlobalData Plc

​GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.

Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.

Other Reports from GlobalData Plc

ResearchPool Subscriptions

Get the most out of your insights

Get in touch